Skip to content

The Change of the Tetanus Antibody Titer After Single Injection of Td and Simultaneous Injection of TIG With Td

the Change of the Tetanus Antibody Titer After Single Injection of Tetanus Vaccine and Simultaneous Injection of Tetanus Immunoglobulin With Tetanus Vaccine?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01338688
Enrollment
250
Registered
2011-04-19
Start date
2008-10-31
Completion date
2010-10-31
Last updated
2011-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tetanus

Brief summary

The investigators want to determine whether TIG influences the formation of tetanus antibody after simultaneous tetanus vaccination according to age and the time-interval of the last tetanus vaccination.

Detailed description

When an injured patient visits the ED, unnecessary injection of tetanus immunoglobulin (TIG) may cause side effects and also increase the medical expense.5 Further, the opportunity of assessing a rising tetanus antibody titer may be missed after simultaneous injection of tetanus-diphtheria vaccine (Td) and TIG. According to age, the elevation of the tetanus antibody titer after tetanus prophylaxis might be not equivalent because of different levels of basal immunity and the time-interval of the last tetanus vaccination. Therefore, we wanted to determine whether TIG influences the formation of tetanus antibody after simultaneous tetanus vaccination according to age and the time-interval of the last tetanus vaccination.

Interventions

None listed

Sponsors

Seoul National University Boramae Hospital
CollaboratorOTHER
Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 89 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy adult volunteers

Exclusion criteria

* immunocompromised * febrile * allergy to the vaccine constituents * previous tetanus immunization within 5 years * medical and non-medical employees

Design outcomes

Primary

MeasureTime frameDescription
The change from baseline in tetanus antibody titer at 4weeks, 6 months and 12monthsBaseline, 4 weeks, 6 months, 12 monthsThe tetanus antibody titers were determined by ELISA and the results were reported in IU/mL. The measurement of tetanus antibody titer at 4 weeks should be needed to check the peak titer after vaccination. the change of tetanus antibody titers were calculated by geometric mean titers(GMTs), and we compared the GMTs between the groups(Td vs Td-TIG)at baseline, 4weeks, 6months, and 12 months by independent T-test.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026